October is supposed to be the month when the box office gets interesting, and this weekend was a perfect, slightly lopsided example of why. One movie arrived with terrible reviews, a brutal audience grade, and a premise designed to make parents check the hallway twice before bed — and it won the weekend going away. The other arrived with one of the most celebrated screenwriters in Hollywood, a cast full of awards-season favorites, and the weight of a modern classic behind it — and it landed in fifth place with a thud you could hear from the back row.
Other Mommy, the new horror film from Universal in partnership with Blumhouse and Atomic Monster, opened at No. 1 with $27.5 million in North America from 3,365 theaters. Add $17.7 million from international markets and the worldwide start is $45.2 million. That is not a monster number by blockbuster standards, but context is everything in horror, and the context here is wonderful for everyone who signed the checks: the film cost roughly $18 to $19 million to make. In other words, before the second weekend even starts, Other Mommy has already covered its production budget on domestic ticket sales alone. Everything from here is gravy, popcorn money, and a very pleasant Monday morning meeting at the studio.
Directed by Rob Savage and based on Josh Malerman's novel Incidents Around the House, the film stars Jessica Chastain in the kind of role that looks exhausting in the best way — the adult in the house who can tell something is deeply, specifically wrong while everyone around her is still catching up. Malerman knows this territory. He wrote the book that became Bird Box, and he has a gift for taking a simple domestic fear and turning the screws until a normal home feels like the least safe place on earth. A strange presence, a child who may not be telling adults everything she knows, a family trying to sound calm while panic rises underneath — it is catnip for October audiences, and October audiences responded exactly the way the genre reliably makes them respond.
What makes the win more remarkable is everything that should have slowed it down. Critics were harsh — genuinely harsh, not the polite mixed kind. One major review called the film “excruciating,” a word that usually sends a movie straight to streaming purgatory. Audiences who bought tickets were not much kinder on the way out: the film earned a D+ CinemaScore, a grade that normally signals word of mouth so poisonous a second weekend falls off a cliff. And yet the opening beat forecasts handily. Going into the weekend, expectations sat closer to $20 million. The film cleared that by more than a third.
There is a lesson in that gap, and Hollywood relearns it every single fall: horror fans do not buy tickets the way prestige audiences do. They are not waiting for a consensus. They are buying an experience — a dark room, a crowd that gasps at the same time, a story they can argue about in the parking lot. A bad review can even help, in a perverse way, because it turns the film into a dare. Is it really that intense? Is it really that divisive? For a $18 million movie in the second weekend of October, a dare is a marketing strategy all by itself. Industry watchers currently project a final domestic run in the $55 to $60 million range, which would be a tidy, profitable finish for a film the critical establishment largely told people to skip.
Now, the other side of the ledger — and we say this with genuine affection, because the talent involved deserves better weekends than this one.
The Social Reckoning, from Sony, opened at No. 5 with $5.5 million from 2,606 theaters. International markets added $3.5 million for a $9.0 million worldwide start. The budget was around $30 million, modest by studio standards, and the studio had hoped for something closer to $8 million domestically on opening weekend. Missing a modest target is in some ways more telling than missing an ambitious one. This was not a film that needed to be a phenomenon. It needed to be a respectable adult drama with buzz, and on opening weekend, the audience for that simply did not materialize in the numbers anyone wanted.
The pedigree could hardly be stronger. Aaron Sorkin wrote and directed it as a follow-up to The Social Network, the 2010 film that turned the founding of Facebook into Shakespeare with laptops. The cast is stacked: Mikey Madison, fresh off a career-defining run, Jeremy Allen White bringing that coiled, sympathetic intensity he does better than almost anyone, and Jeremy Strong stepping into the role of Mark Zuckerberg, succeeding Jesse Eisenberg, whose twitchy, brilliant performance in the original became instantly iconic. Strong is a fearless actor, and the idea of him taking on that character — older, more powerful, more embattled — is fascinating on paper. Fascinating on paper, however, is not the same thing as urgent on a Friday night.
The comparison to the original is unavoidable, and it is unkind. The Social Network opened at $22.4 million in October 2010 — in a very different theatrical market, it should be said — and went on to finish with about $224 million worldwide, plus a permanent place in the culture. It arrived when the story of social media still felt like a origin myth audiences were hungry to hear. Sixteen years later, a film asking audiences to sit with what those platforms became is asking for a different, heavier kind of evening. People live inside that story now. Living inside it may make them less eager to buy a ticket to revisit it, at least on opening weekend, at least against a scary movie with a title that gets under your skin in two words.
Its B- CinemaScore suggests the people who did go were lukewarm rather than hostile — not the disaster of a D+, but not the kind of grade that builds a long, leggy run either. There is still a path for a well-reviewed adult drama to find its audience slowly, on streaming and through awards conversation, and nobody should write the obituary for a Sorkin film after three days. But the theatrical chapter of this story has started quietly, and quietly is not what Sony needed.
The rest of the top five filled in around the two newcomers. Verity held at No. 2 with $11.5 million in its second weekend, reaching $53.9 million overall. Resident Evil continued its impressive run at No. 3 with $8.4 million in its fourth weekend and $138.5 million domestic to date — a figure we dig into in our story on its new franchise record. Heart of the Beast took No. 4 with $7.1 million in its third weekend, at $49.7 million total. And then The Social Reckoning rounded out the five.
Zoom out and the weekend itself was solid enough: about $85.2 million across all releases, and the 2026 domestic box office has now crossed the $8 billion mark, sitting at $8.07 billion year to date. That milestone matters. It says audiences are still coming, still spending, still treating the theater as a place worth going — they are just being very particular about what pulls them off the couch. This weekend they chose a haunted house over a boardroom, and honestly, in October, could anyone really be surprised?
Rentrak analyst Paul Dergarabedian put the broader pattern well, noting in essence that October is the month when studios take their chances — releasing the odd, the risky, and the hard-to-categorize — and that those gambles do not always pay off. That is the generous and accurate way to read this weekend. Both of these films were chances. One was a low-budget horror gamble from producers who have turned that exact bet into an empire. The other was a prestige gamble that a serious drama about the most consequential company of the century could still command a theatrical audience on the strength of its writing and cast.
Only one of those bets cashed. But here is the good-natured truth we should end on: a business where both bets get placed is healthier than a business where only the safe one does. Horror keeps the lights on, quite literally, with cheap scares and reliable crowds. Prestige drama keeps the art form ambitious, even when a particular title stumbles out of the gate. Other Mommy gets its victory lap, Chastain gets another hit to her name, and Sorkin — who has survived far worse weekends in a long career — gets to find out whether his reckoning finds its people a little later. October still has weeks to go. The box office, like the movies themselves, loves a second act.
Keep up with every major opening in our news coverage and browse what's playing next in our movies section.
